292 related articles for article (PubMed ID: 30854032)
41. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
[TBL] [Abstract][Full Text] [Related]
42. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
Brockhausen I; Yang J; Lehotay M; Ogata S; Itzkowitz S
Biol Chem; 2001 Feb; 382(2):219-32. PubMed ID: 11308020
[TBL] [Abstract][Full Text] [Related]
43. Chemoenzymatic Synthesis of Asymmetrical Multi-Antennary N-Glycans to Dissect Glycan-Mediated Interactions between Human Sperm and Oocytes.
Chinoy ZS; Friscourt F; Capicciotti CJ; Chiu P; Boons GJ
Chemistry; 2018 Jun; 24(31):7970-7975. PubMed ID: 29603480
[TBL] [Abstract][Full Text] [Related]
44. Simple sugars to complex disease--mucin-type O-glycans in cancer.
Kudelka MR; Ju T; Heimburg-Molinaro J; Cummings RD
Adv Cancer Res; 2015; 126():53-135. PubMed ID: 25727146
[TBL] [Abstract][Full Text] [Related]
45. Carcinoembryonic antigen carrying SLe
Gomes C; Almeida A; Barreira A; Calheiros J; Pinto F; Abrantes R; Costa A; Polonia A; Campos D; Osório H; Sousa H; Pinto-de-Sousa J; Kolarich D; Reis CA
Theranostics; 2019; 9(24):7431-7446. PubMed ID: 31695778
[TBL] [Abstract][Full Text] [Related]
46. Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.
Madsen CB; Lavrsen K; Steentoft C; Vester-Christensen MB; Clausen H; Wandall HH; Pedersen AE
PLoS One; 2013; 8(9):e72413. PubMed ID: 24039759
[TBL] [Abstract][Full Text] [Related]
47. Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells.
Wilkins PP; McEver RP; Cummings RD
J Biol Chem; 1996 Aug; 271(31):18732-42. PubMed ID: 8702529
[TBL] [Abstract][Full Text] [Related]
48. Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines.
Bassagañas S; Allende H; Cobler L; Ortiz MR; Llop E; de Bolós C; Peracaula R
Cytokine; 2015 Sep; 75(1):197-206. PubMed ID: 25934648
[TBL] [Abstract][Full Text] [Related]
49. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers.
Nakano M; Nakagawa T; Ito T; Kitada T; Hijioka T; Kasahara A; Tajiri M; Wada Y; Taniguchi N; Miyoshi E
Int J Cancer; 2008 May; 122(10):2301-9. PubMed ID: 18214858
[TBL] [Abstract][Full Text] [Related]
50. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
[TBL] [Abstract][Full Text] [Related]
51. Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives.
Berois N; Pittini A; Osinaga E
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158915
[TBL] [Abstract][Full Text] [Related]
52. Diverse monoclonal antibodies against the CA 19-9 antigen show variation in binding specificity with consequences for clinical interpretation.
Partyka K; Maupin KA; Brand RE; Haab BB
Proteomics; 2012 Jul; 12(13):2212-20. PubMed ID: 22623153
[TBL] [Abstract][Full Text] [Related]
53. Altered tumor-cell glycosylation promotes metastasis.
Häuselmann I; Borsig L
Front Oncol; 2014; 4():28. PubMed ID: 24592356
[TBL] [Abstract][Full Text] [Related]
54. Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis.
Rodrigues JG; Balmaña M; Macedo JA; Poças J; Fernandes Â; de-Freitas-Junior JCM; Pinho SS; Gomes J; Magalhães A; Gomes C; Mereiter S; Reis CA
Cell Immunol; 2018 Nov; 333():46-57. PubMed ID: 29576316
[TBL] [Abstract][Full Text] [Related]
55. Increased levels of acidic free-N-glycans, including multi-antennary and fucosylated structures, in the urine of cancer patients.
Hanzawa K; Tanaka-Okamoto M; Murakami H; Suzuki N; Mukai M; Takahashi H; Omori T; Ikezawa K; Ohkawa K; Ohue M; Natsuka S; Miyamoto Y
PLoS One; 2022; 17(4):e0266927. PubMed ID: 35413075
[TBL] [Abstract][Full Text] [Related]
56. The Cosmc connection to the Tn antigen in cancer.
Ju T; Aryal RP; Kudelka MR; Wang Y; Cummings RD
Cancer Biomark; 2014 Jan; 14(1):63-81. PubMed ID: 24643043
[TBL] [Abstract][Full Text] [Related]
57. An Immunohistochemical Evaluation of Tumor-Associated Glycans and Mucins as Targets for Molecular Imaging of Pancreatic Ductal Adenocarcinoma.
Houvast RD; Thijse K; Groen JV; Chua J; Vankemmelbeke M; Durrant LG; Mieog JSD; Bonsing BA; Vahrmeijer AL; Kuppen PJK; Crobach ASLP; Sier CFM
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830932
[TBL] [Abstract][Full Text] [Related]
58. Alteration of N-glycosylation in the kidney in a mouse model of systemic lupus erythematosus: relative quantification of N-glycans using an isotope-tagging method.
Hashii N; Kawasaki N; Itoh S; Nakajima Y; Kawanishi T; Yamaguchi T
Immunology; 2009 Mar; 126(3):336-45. PubMed ID: 18710403
[TBL] [Abstract][Full Text] [Related]
59. Investigation of acidic free-glycans in urine and their alteration in cancer.
Hanzawa K; Tanaka-Okamoto M; Murakami H; Mukai M; Takahashi H; Omori T; Ikezawa K; Ohkawa K; Ohue M; Miyamoto Y
Glycobiology; 2021 May; 31(4):391-409. PubMed ID: 33135073
[TBL] [Abstract][Full Text] [Related]
60. Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.
Ju T; Wang Y; Aryal RP; Lehoux SD; Ding X; Kudelka MR; Cutler C; Zeng J; Wang J; Sun X; Heimburg-Molinaro J; Smith DF; Cummings RD
Proteomics Clin Appl; 2013 Oct; 7(9-10):618-31. PubMed ID: 23857728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
